Raymond James Downgrades athenahealth (ATHN) to Outperform
Tweet Send to a FriendGet Alerts ATHN Hot Sheet
Price: $85.82 +0.68%
Rating Summary:
7 Buy, 12 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Rating Summary:
7 Buy, 12 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Trade ATHN Now!
Raymond James downgraded athenahealth (NASDAQ: ATHN) from Strong Buy to Outperform with a price target of $95.00 (from $85.00).
For an analyst ratings summary and ratings history on athenahealth click here. For more ratings news on athenahealth click here.
Shares of athenahealth closed at $87.42 yesterday, with a 52 week range of $56.33-$97.37.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on athenahealth click here. For more ratings news on athenahealth click here.
Shares of athenahealth closed at $87.42 yesterday, with a 52 week range of $56.33-$97.37.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: MKM Partners Downgrades Alkermes (ALKS) to Sell
- Bulls and Bears Do Battle in Aeropostale (ARO); Turnaround Intact?
- Janney Montgomery Scott Downgrades Cubist Pharmaceuticals (CBST) to Neutral
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesRelated Entities
Raymond James
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
